137 related articles for article (PubMed ID: 18563707)
1. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).
Purper-Ouakil D; Wohl M; Orejarena S; Cortese S; Boni C; Asch M; Mouren MC; Gorwood P
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1425-30. PubMed ID: 18563707
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
[TBL] [Abstract][Full Text] [Related]
3. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
McGough JJ; McCracken JT; Loo SK; Manganiello M; Leung MC; Tietjens JR; Trinh T; Baweja S; Suddath R; Smalley SL; Hellemann G; Sugar CA
J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1155-64. PubMed ID: 19858760
[TBL] [Abstract][Full Text] [Related]
4. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
Kambeitz J; Romanos M; Ettinger U
Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
[TBL] [Abstract][Full Text] [Related]
6. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
Bonvicini C; Faraone SV; Scassellati C
Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
Roman T; Rohde LA; Hutz MH
Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
Gruber R; Joober R; Grizenko N; Leventhal BL; Cook EH; Stein MA
J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):233-9. PubMed ID: 19519258
[TBL] [Abstract][Full Text] [Related]
15. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.
Roman T; Szobot C; Martins S; Biederman J; Rohde LA; Hutz MH
Pharmacogenetics; 2002 Aug; 12(6):497-9. PubMed ID: 12172219
[TBL] [Abstract][Full Text] [Related]
18. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.
Mick E; Biederman J; Spencer T; Faraone SV; Sklar P
Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):890-4. PubMed ID: 16917950
[TBL] [Abstract][Full Text] [Related]
19. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J
J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191
[TBL] [Abstract][Full Text] [Related]
20. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
Tharoor H; Lobos EA; Todd RD; Reiersen AM
Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]